News

Feb 04,2022

Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing

Jan 27,2022

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

Jan 18,2022

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into the Clinics

Dec 01,2021

ITabMed Completes Series A-round Financing after Spin-off

Nov 30,2021

Expert Opinion on Investigational Drugs Publishes "An Evaluation of KBP-5074 in Advanced CKD with Uncontrolled Hypertension"

Nov 28,2021

KBP Participates in the 6th Kidney Disease Clinical Trialists Workshop

Nov 09,2021

OncoC4, Inc. Reports Phase Ia Data on Safety and Clinical Activities of ONC-392 (Nextgen Anti-CTLA-4) Monotherapy for Stage IV Solid Tumors

Oct 14,2021

Immune-Onc Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4), in Patients With Advanced Solid Tumors

No more pages to load

Next page